A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP

Coronavirus: Antiviral that has ‘shown promise’ among US biomedical agency’s drug tests, after patient responds to remdesivir medication

  • Gilead Sciences’ remdesivir was initially developed to fight the Ebola virus, and the company is working with Chinese health officials on a clinical trial
  • The first coronavirus patient in the United States was treated with remdesivir in late January and his symptoms improved
Topic |   Coronavirus outbreak

TOP PICKS

A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP
READ FULL ARTICLE
Robert Delaney

Robert Delaney

Robert Delaney is the Post’s North America bureau chief. He spent 11 years in China as a language student and correspondent for Dow Jones Newswires and Bloomberg, and continued covering the country as a correspondent and an academic after leaving. His debut novel, The Wounded Muse, draws on actual events that played out in Beijing while he lived there.